Synergistic combination of monoamine oxidase inhibitor, presynaptic 5-HT1A antagonist and 5HT1A agonist for treating depression

摘要

Synergistic compositions containing a monoamine oxidase inhibitor (I), a pre-synaptic 5-HT1A antagonist, and a 5-HT1A agonist, are new. Pharmaceutical composition comprises a monoamine oxidase inhibitor (I), a pre-synaptic 5-HT1A antagonist and a 5-HT1A agonist are new.